180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering…
<!-- Name:DistributionId Value:8805071 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
180 Life Sciences Corp.
180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytren’s…
<!-- Name:DistributionId Value:8755029 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
180 Life Sciences Provides Update on Progress To Seek Medicines and Healthcare…
PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the Company and its regulatory…
CORRECTION: Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage…
PALO ALTO, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- A correction has been issued for the release disseminated under the same headline on Thursday, November 15th by 180 Life Sciences…
180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S.…
PALO ALTO, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the…
180 Life Sciences Corp. To Participate in the Biotech Showcase 2022 Virtual…
PALO ALTO, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the…
180 Life Sciences Provides Follow-Up Information on Oxford University and the…
PALO ALTO, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the…
180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address…
PALO ALTO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the…